Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
- 682-30 - PREGABALIN 60760 682 30
- pregabalin-equation - pregabalin equation
- pregabalin-fig-a - pregabalin fig a
- pregabalin-Figure-6 - pregabalin figure 6
- pregabalin-Figure-7 - pregabalin figure 7
- Study DPN 1 - pregabalin image 1
- Study SCI 1 - pregabalin image 10
- Pain Intensity-study SCI 2 - pregabalin image 11
- Study DPN 2 - pregabalin image 2
- Study PHN 1 - pregabalin image 3
- Study PHN 2 - pregabalin image 4
- Study PHN 3 - pregabalin image 5
- Fibromyalgia Study F1 - pregabalin image 8
- Fibromyalgia Study F2 - pregabalin image 9
- Pregabalin structure - pregabalin srtuc 1
Product Label Images
The following 15 images provide visual information about the product associated with Pregabalin NDC 60760-682 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
682-30 - PREGABALIN 60760 682 30

This is a product label for Pregabalin capsules (150mg) manufactured by Alkem Laboratories Ltd. The label includes important information such as NDC numbers, lot numbers, expiration dates, and storage instructions (Store at controlled room temperature 15°-30°C). It is important to use the medication as directed.*
pregabalin-Figure-6 - pregabalin figure 6

This is a summary of multiple studies evaluating different doses of a medication compared to a placebo. The studies include varying doses of the medication administered daily. The results show percentages for each study group, indicating statistical significance compared to the placebo group.*
Study PHN 2 - pregabalin image 4

This text appears to contain information about a study involving patients taking different doses of Pregabalin and a placebo. The text also mentions the improvement of pain compared to baseline.*
Fibromyalgia Study F1 - pregabalin image 8

This text provides data on the percentage of patients improved based on different doses of the drug Pregabalin. It shows the improvement in pain from baseline for various doses including 100mg, 450mg, 300mg, and a placebo group. The information appears to be part of a study or report analyzing the effectiveness of Pregabalin in managing pain.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.